- Press Release -

Rockville, Md. The global prefilled auto-injectors market is set to exceed US$ 3.616 Bn by 2022 at a double-digit CAGR, according to Fact.MR, as an expanding range of biotech drugs meets rising demand for convenient self-injection. Patients increasingly trust these devices for their reliability, and their centric design helps those with needle phobia overcome the reluctance tied to self-injection.

North America leads the market, anaphylaxis is the dominant indication, and online pharmacies are the largest channel. Asia Pacific excluding Japan is the fastest-growing region.

Indications, Channels and Regions

Anaphylaxis is the leading use, with nearly US$ 3.2 Bn of auto-injectors expected to serve it by 2022. On distribution, online pharmacies are the largest channel at about 33% of revenue, heading toward nearly US$ 1.5 Bn by 2022. Ongoing advances keep improving device accuracy and reliability, and manufacturers are extending auto-injectors into new therapeutic areas.

North America retains its dominant position on a large pool of patients requiring daily drug administration, while Asia Pacific excluding Japan surges at just under a 16% CAGR on low device costs and rapid healthcare expansion, and Europe holds over 10% of revenue.

Convenience Drives Demand

The market runs on ease and safety. As biotech therapies proliferate and patients favour self-injection over conventional needles and syringes that can cause injury, prefilled auto-injectors keep gaining ground, with needle-phobic users a notable and growing segment.

Suppliers and Their Playbook

The field brings together pharmaceutical and drug-delivery device makers.

• Eli Lilly and Company, Becton, Dickinson and Company, Mylan N.V., Amgen Inc., Pfizer Inc., and Antares Pharma, Inc. are among the key players in the report.

Reading the Market for Decisions

For device makers, growth favours accurate, easy-to-use injectors and expansion into new therapeutic areas. Investors get a fast-growing market with a firm clinical tailwind. Procurement and pharmacy teams can plan around anaphylaxis carrying volume, online pharmacies leading distribution, and North America offering the largest opportunity while Asia Pacific grows fastest through 2022.

About the Report

Fact.MR's study covers the global prefilled auto-injectors market for the 2017 to 2022 forecast period, with segmentation by indication, distribution channel and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the prefilled auto-injectors market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.